Shares in Molecular Devices Fall 17 Percent | GenomeWeb
Molecular Devices’ stock lost 16.9 percent of its value for the trading week ended Tuesday, following last week’s announcement that it was lowering its revenue guidance for the third quarter (see related article). The firm led all eight decliners for the trading period. Meanwhile, Stratagene shares gained 10.7 percent to lead all issues in the BCW Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.